Tong S - Search Results

1

LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway.

Wang J, Xiao Q, Chen X, Tong S, Sun J, Lv R, Wang S, Gou Y, Tan L, Xu J, Fan C, Ding G. Wang J, et al. Among authors: tong s. Cell Death Dis. 2018 Feb 7;9(2):197. doi: 10.1038/s41419-017-0207-0. Cell Death Dis. 2018. PMID: 29416001 Free PMC article.

2

Overexpression of WDFY2 inhibits prostate cancer cell growth and migration via inactivation of Akt pathway.

Wang J, Chen X, Tong S, Zhou H, Sun J, Gou Y, Wu F, Hu J, Xu J, Ding G. Wang J, et al. Among authors: tong s. Tumour Biol. 2017 Jun;39(6):1010428317704821. doi: 10.1177/1010428317704821. Tumour Biol. 2017. PMID: 28653900 Free article.

3

Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.

Ding G, Fang J, Tong S, Qu L, Jiang H, Ding Q, Liu J. Ding G, et al. Among authors: tong s. Prostate. 2015 Jun 15;75(9):957-68. doi: 10.1002/pros.22978. Epub 2015 Feb 25. Prostate. 2015. PMID: 25728945

4

Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.

Hu Q, Tong S, Zhao X, Ding W, Gou Y, Xu K, Sun C, Xia G. Hu Q, et al. Among authors: tong s. Cell Physiol Biochem. 2015;36(2):799-809. doi: 10.1159/000430139. Epub 2015 May 22. Cell Physiol Biochem. 2015. PMID: 26021267 Free article.

5

Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis.

Ding G, Sun J, Jiang L, Gao P, Zhou Q, Wang J, Tong S. Ding G, et al. Among authors: tong s. Open Med (Wars). 2020 Oct 9;15(1):1039-1047. doi: 10.1515/med-2020-0237. eCollection 2020. Open Med (Wars). 2020. PMID: 33336059 Free PMC article.

6

Outcomes and trends of prostate biopsy for prostate cancer in Chinese men from 2003 to 2011.

Na R, Jiang H, Kim ST, Wu Y, Tong S, Zhang L, Xu J, Sun Y, Ding Q. Na R, et al. Among authors: tong s. PLoS One. 2012;7(11):e49914. doi: 10.1371/journal.pone.0049914. Epub 2012 Nov 26. PLoS One. 2012. PMID: 23189170 Free PMC article.

7

Are EORTC risk tables suitable for Chinese patients with non-muscle-invasive bladder cancer?

Ding W, Chen Z, Gou Y, Sun C, Xu K, Tan J, Tong S, Xia G, Ding Q. Ding W, et al. Among authors: tong s. Cancer Epidemiol. 2014 Apr;38(2):157-61. doi: 10.1016/j.canep.2014.02.001. Epub 2014 Mar 11. Cancer Epidemiol. 2014. PMID: 24629527

8

The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer.

Chen Z, Ding W, Xu K, Tan J, Sun C, Gou Y, Tong S, Xia G, Fang Z, Ding Q. Chen Z, et al. Among authors: tong s. PLoS One. 2012;7(10):e47199. doi: 10.1371/journal.pone.0047199. Epub 2012 Oct 17. PLoS One. 2012. PMID: 23082147 Free PMC article.

9

Human epidermal growth factor receptor 2: a significant indicator for predicting progression in non-muscle-invasive bladder cancer especially in high-risk groups.

Ding W, Tong S, Gou Y, Sun C, Wang H, Chen Z, Tan J, Xu K, Xia G, Ding Q. Ding W, et al. Among authors: tong s. World J Urol. 2015 Dec;33(12):1951-7. doi: 10.1007/s00345-015-1557-9. Epub 2015 Apr 18. World J Urol. 2015. PMID: 25894367

10

The Huashan risk calculators performed better in prediction of prostate cancer in Chinese population: a training study followed by a validation study.

Wu YS, Zhang N, Liu SH, Xu JF, Tong SJ, Cai YH, Zhang LM, Bai PD, Hu MB, Jiang HW, Na R, Ding Q, Sun YH. Wu YS, et al. Asian J Androl. 2016 Nov-Dec;18(6):925-929. doi: 10.4103/1008-682X.181192. Asian J Androl. 2016. PMID: 27212127 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,747 results

Search Page

Filters